Ethnic skin disorders overview

Journal of the American Academy of Dermatology

Volumn 48, Issue 6 SUPPL., 2003, Pages

  Halder, Rebat M ^a,b   Nootheti, Pavan K ^a  

^a HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b HOWARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACNE; AGING; ASIAN; CAUCASIAN; CHLOASMA; CONFERENCE PAPER; DEMOGRAPHY; DERMATOLOGY; ETHNIC DIFFERENCE; ETHNIC GROUP; HUMAN; HYPERPIGMENTATION; HYPOPIGMENTATION; PIGMENT DISORDER; PRIORITY JOURNAL; RACE DIFFERENCE; RISK FACTOR; SKIN COLOR; SKIN DISEASE; SKIN PIGMENTATION; TREATMENT PLANNING; UNITED STATES; VITILIGO;

EID: 0037778009     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2003.274     Document Type: Conference Paper

References (43)

1. Projections of the resident population by race, Hispanic origin, and nativity: middle series, 2006 to 2010. Washington, DC: Populations Projections Program, Population Division, U.S. Census Bureau.
2. Projections of the resident population by race, Hispanic origin, and nativity: middle series, 2050 to 2070. Washington, DC: Populations Projections Program, Population Division, U.S. Census Bureau.
3. Halder RM, Grimes PE, McLaurin CI, Kress MA, Kenney JA Jr. Incidence of common dermatoses in a predominantly black dermatologic practice. Cutis 1983;32:378-80.
4. Child FJ, Fuller LC, Higgins EM, Du Vivier AWP. A study of the spectrum of skin disease occurring in a black population in south-east London. Br J Dermatol 1999;141:512-17.
5. Halder RM, Holmes YC, Bridgemen-Shah S, Kligman AM. A clinicohistopathologic study of acne vulgaris in black females [abstract]. J Invest Dermatol 1996;106:495A.
6. Halder RM. The role of retinoids in the management of cutaneous conditions in blacks. J Am Acad Dermatol 1998;39:S98-S103.
7. Jacyk WK, Mpofu P. Adapalene gel 0.1% for topical treatment of acne vulgaris in African patients. Cutis 2001;68:48-54.
8. Kelly AP, Sampson DD. Recalcitrant nodulocystic acne in black Americans: treatment with isotretinoin. J Natl Med Assoc 1987;79:1266-70.
9. Fitton A, Goa KL. Azelaic acid. A review of its pharmacological properties and therapeutic efficacy in acne and hyperpigmentary skin disorders. Drugs 1991;41:780-98.
10. Balina LM, Graupe K. The treatment of melasma. 20% azelaic acid versus 4% hydroquinone cream. Int J Dermatol 1991;30:893-5.
11. Glenn M, Grimes PE, Pitt E, Chalet M, Kelly AP. Evaluation of clinical and light microscopic effects of various concentrations of hydroquinone [abstract]. Clin Res 1991;39:83A.
12. Porter J. The psychological effects of vitiligo: response to impaired appearance. In: Hann S-K, Nordlund JJ, editors. Vitiligo. Oxford, London: Blackwell Science; 2000. p. 97-100.
13. Morelli JG, Norris DA. Influence of inflammatory mediators and cytokines in human melanocyte function. J Invest Dermatol 1993;100:191S-5S.
14. Morelli JG, Kincannon J, Yohn JJ, Zekman T, Weston WL, Norris DA. Leukotriene C4 and TGF-alpha are stimulators of human melanocyte migration in vitro. J Invest Dermatol 1992;98:290-5.
15. Hoshaw RA, Zimmerman KG, Menter A. Onchronosis-like pigmentation from hydroquinone bleaching creams in American blacks. Arch Dermatol 1985;121:105-8.
16. Kramer K, Lopez A, Stefanato CM, Phillips TJ. Exogenous ochronosis. J Am Acad Dermatol 2000;42:869-71.
17. Kligman AM, Willis IA. New formula for depigmenting human skin. Arch Dermatol 1975;111:40-8.
18. Bulengo-Ransby SM, Griffiths CE, Kimbrough-Green CK, Finkel LJ, Hamilton TA, Ellis CN. Topical tretinoin (retinoic acid) therapy for hyperpigmented lesions caused by inflammation of the skin in black patients. N Engl J Med 1993;328:1438-43.
19. Grimes PE. The safety and efficacy of salicylic acid chemical peels in darker racial-ethic groups. Dermatol Surg 1999;25:18-22.
20. Burns RL, Prevost-Blank PL, Lawry MA, Lawry TB, Faria DT, Fivenson DP. Glycolic acid peels for postinflammatory hyperpigmentation in black patients: a comparative study. Dermatol Surg 1997;23:171-4.
21. Halder RM, Nordlund JJ. Laser treatment of pigmentary disorders. In: Nordlund JJ, Boissy RE, Hearing VJ, King RA, Ortonne JP, editors. The pigmentary system: physiology and pathophysiology. New York: Oxford University Press; 1998. p. 995-8.
22. McMichael AJ. Review of cutaneous disease in African-American patients. Dermatol Nurs 1999;11:35-6, 41-7.
23. McLaurin CI. Unusual patterns of common dermatoses in blacks. Cutis 1983;32:352-5, 358-600.
24. Halder RM, Nordlund JJ. Phototherapy for pigmentary disorders. In: Nordlund JJ, Boissy RE, Hearing VJ, King RA, Ortonne JP, editors. The pigmentary system: physiology and pathophysiology. New York, NY: Oxford University Press; 1998. p. 977-83.
25. Westerhof W, Nieuweboer-Krobotova L. Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A. Arch Dermatol 1997;133:1525-8.
26. Halder RM, Young CM. New and emerging therapies for vitiligo. Dermatol Clin 2000;18:79-89.
27. Nordlund JJ, Halder RM, Grimes P. Management of vitiligo. Dermatol Clin 1993;11:27-33.
28. Grimes PE. Melasma: etiologic and therapeutic considerations. Arch Dermatol 1995;131:1453-7.
29. Snider RL, Thiers BH. Exogenous ochronosis. J Am Acad Dermatol 1993;28:662.
30. Kimbrough-Green CK, Griffiths CEM, Finkel LJ, Hamilton TA, Bulengo-Ransby SM, Ellis CN, et al. Topical retinoic acid (tretinoin) for melasma in black patients: a vehicle-controlled clinical trial. Arch Dermatol 1994;130:727-33.
31. Verallo-Rowell VM, Verallo V, Graupe K, Lopez-Villafuerte L, Garcia-Lopez M. Double-blind comparison of azelaic acid and hydroquinone in the treatment of melasma. Acta Derm Venereol 1989;143(Suppl):58-61.
32. Breathnach AS. Melanin hyperpigmentation of skin: melasma, topical treatment with azelaic acid, and other therapies. Cutis 1996;57:S36-S45.
33. Taylor SC. Cosmetic problems in skin of color. Skin Pharmacol Appl Skin Physiol 1999;12:139-43.
34. Taylor CR, Anderson RR. Ineffective treatment of refractory melasma and postinflammatory hyperpigmentation by Q-switched ruby laser. J Dermatol Surg Oncol 1994;20:592-7.
35. Kligman AM. Early destructive effect of sunlight on human skin. JAMA 1969;210:2377-80.
36. Griffiths CEM. Assessment of topical retinoids for the treatment of Far-East Asian Skin. J Am Acad Dermatol 1998;38:S104-7.
37. Fulton JE, Pay SR. Comedogenicity of current therapeutic products, cosmetics, and ingredients in the rabbit ear. J Am Acad Dermatol 1984;10:96-105.
38. Stoner JG. Miscellaneous dermatitis-inducing plants. Clin Derm 1986;4:94-101.
39. Look KM, Look RM. Skin scarping, cupping, and moxibustion that may mimic physical abuse. J Forensic Sci 1997;42:103-5.
40. Turner RN, Low RH. The principles and practice of moxibustion. Wellingborough (UK): Thorsons Publishers Ltd; 1992.
41. O'Connor J, Bensky D, editors. Acupuncture: a comprehensive text. Seattle (WA): Eastland Press; 1981.
42. Wong HCG, Wong JKT, Wong NYY. Signs of physical abuse or evidence of moxibustion, cupping or coining? CMAJ 1999;160:785-6.
43. Rothschild SK. Cross-cultural issues in primary care medicine. Dis Mon 1998;44:293-319.